Alzheimer's Disease Trial, Recruiting (NCT07482072)

Alzheimer's Disease Trial, Recruiting NCT07482072 Sponsor: Rigshospitalet, Denmark Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07482072 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been assessed as possibly having Alzheimer's disease
You have been diagnosed with type 2 diabetes (for Group A participants)
You are willing and able to follow the study's rules and procedures

Who may not be able to join:

You have type 2 diabetes and are being considered for Group B or Group C of the study
You have a significant brain condition other than dementia (for Group A and Group B participants)
You have a serious condition affecting your blood vessels or nervous system (for Group C participants)
You are currently receiving treatment for cancer
You have a history of misusing alcohol or drugs
You have severe claustrophobia (a strong fear of enclosed spaces, such as an MRI scanner)
You are pregnant or currently breastfeeding

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4538682041

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07482072

Sponsor: Rigshospitalet, Denmark

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: +4538682041

More information: https://clinicaltrials.gov/study/NCT07482072

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been assessed as possibly having Alzheimer's disease
You have been diagnosed with type 2 diabetes (for Group A participants)
You are willing and able to follow the study's rules and procedures

Who may not be able to join:

You have type 2 diabetes and are being considered for Group B or Group C of the study
You have a significant brain condition other than dementia (for Group A and Group B participants)
You have a serious condition affecting your blood vessels or nervous system (for Group C participants)
You are currently receiving treatment for cancer
You have a history of misusing alcohol or drugs
You have severe claustrophobia (a strong fear of enclosed spaces, such as an MRI scanner)
You are pregnant or currently breastfeeding

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Rigshospitalet, Denmark

Registry

ClinicalTrials.gov

Start date

1 March 2026

Est. completion

1 December 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Glucose transport

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov